These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22386665)

  • 1. 3-Phenyl-5-isothiazole carboxamides with potent mGluR1 antagonist activity.
    Fisher MJ; Backer RT; Barth VN; Garbison KE; Gruber JM; Heinz BA; Iyengar S; Hollinshead SP; Kingston A; Kuklish SL; Li L; Nisenbaum ES; Peters SC; Phebus L; Simmons RM; van der Aar E
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2514-7. PubMed ID: 22386665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From pyrroles to 1-oxo-2,3,4,9-tetrahydro-1H-beta-carbolines: a new class of orally bioavailable mGluR1 antagonists.
    Di Fabio R; Micheli F; Alvaro G; Cavanni P; Donati D; Gagliardi T; Fontana G; Giovannini R; Maffeis M; Mingardi A; Tranquillini ME; Vitulli G
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2254-9. PubMed ID: 17276684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide].
    Satow A; Maehara S; Ise S; Hikichi H; Fukushima M; Suzuki G; Kimura T; Tanak T; Ito S; Kawamoto H; Ohta H
    J Pharmacol Exp Ther; 2008 Aug; 326(2):577-86. PubMed ID: 18487514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship of triazafluorenone derivatives as potent and selective mGluR1 antagonists.
    Zheng GZ; Bhatia P; Daanen J; Kolasa T; Patel M; Latshaw S; El Kouhen OF; Chang R; Uchic ME; Miller L; Nakane M; Lehto SG; Honore MP; Moreland RB; Brioni JD; Stewart AO
    J Med Chem; 2005 Nov; 48(23):7374-88. PubMed ID: 16279797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research progress of selective mGluR1 antagonists].
    Yang YL; Sun W; Peng C; Zhang XY; Yang XH
    Yao Xue Xue Bao; 2011 Oct; 46(10):1167-72. PubMed ID: 22242445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperidyl amides as novel, potent and orally active mGlu5 receptor antagonists with anxiolytic-like activity.
    Spanka C; Glatthar R; Desrayaud S; Fendt M; Orain D; Troxler T; Vranesic I
    Bioorg Med Chem Lett; 2010 Jan; 20(1):184-8. PubMed ID: 19931453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent nonpeptide antagonists of the bradykinin B1 receptor: structure-activity relationship studies with novel diaminochroman carboxamides.
    Biswas K; Li A; Chen JJ; D'Amico DC; Fotsch C; Han N; Human J; Liu Q; Norman MH; Riahi B; Yuan C; Suzuki H; Mareska DA; Zhan J; Clarke DE; Toro A; Groneberg RD; Burgess LE; Lester-Zeiner D; Biddlecome G; Manning BH; Arik L; Dong H; Huang M; Kamassah A; Loeloff R; Sun H; Hsieh FY; Kumar G; Ng GY; Hungate RW; Askew BC; Johnson E
    J Med Chem; 2007 May; 50(9):2200-12. PubMed ID: 17408249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of (1R,2R)-N-(4-(6-isopropylpyridin-2-yl)-3-(2-methyl-2H-indazol-5-yl)isothiazol-5-yl)-2-methylcyclopropanecarboxamide, a potent and orally efficacious mGlu5 receptor negative allosteric modulator.
    Hao J; Dehlinger V; Fivush AM; Rudyk HC; Britton TC; Hollinshead SP; Vokits BP; Clark BP; Henry SS; Massey SM; Peng L; Dressman BA; Heinz BA; Roberts EF; Bracey-Walker MR; Swanson S; Catlow JT; Love PL; Tepool AD; Peters SC; Simmons RM; Iyengar S; McKinzie DL; Monn JA
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1249-52. PubMed ID: 23374867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between brain/plasma ratios and efficacy in neuropathic pain models of selective metabotropic glutamate receptor 1 antagonists.
    Zheng GZ; Bhatia P; Kolasa T; Patel M; El Kouhen OF; Chang R; Uchic ME; Miller L; Baker S; Lehto SG; Honore P; Wetter JM; Marsh KC; Moreland RB; Brioni JD; Stewart AO
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4936-40. PubMed ID: 16809035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-[Substituted]-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)benzonitriles: identification of highly potent and selective metabotropic glutamate subtype 5 receptor antagonists.
    Tehrani LR; Smith ND; Huang D; Poon SF; Roppe JR; Seiders TJ; Chapman DF; Chung J; Cramer M; Cosford ND
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5061-4. PubMed ID: 16183275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-2,3'-bipyridine: a highly potent, orally active metabotropic glutamate subtype 5 (mGlu5) receptor antagonist with anxiolytic activity.
    Roppe JR; Wang B; Huang D; Tehrani L; Kamenecka T; Schweiger EJ; Anderson JJ; Brodkin J; Jiang X; Cramer M; Chung J; Reyes-Manalo G; Munoz B; Cosford ND
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3993-6. PubMed ID: 15225713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique antipsychotic activities of the selective metabotropic glutamate receptor 1 allosteric antagonist 2-cyclopropyl-5-[1-(2-fluoro-3-pyridinyl)-5-methyl-1H-1,2,3-triazol-4-yl]-2,3-dihydro-1H-isoindol-1-one.
    Satow A; Suzuki G; Maehara S; Hikichi H; Murai T; Murai T; Kawagoe-Takaki H; Hata M; Ito S; Ozaki S; Kawamoto H; Ohta H
    J Pharmacol Exp Ther; 2009 Jul; 330(1):179-90. PubMed ID: 19359526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipyridyl amines: potent metabotropic glutamate subtype 5 receptor antagonists.
    Kamenecka TM; Bonnefous C; Govek S; Vernier JM; Hutchinson J; Chung J; Reyes-Manalo G; Anderson JJ
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4350-3. PubMed ID: 16039855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo SAR of pyrido[3,4-d]pyramid-4-ylamine based mGluR1 antagonists.
    Mantell SJ; Gibson KR; Osborne SA; Maw GN; Rees H; Dodd PG; Greener B; Harbottle GW; Million WA; Poinsard C; England S; Carnell P; Betts AM; Monhemius R; Prime RL
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2190-4. PubMed ID: 19289283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailability.
    Ornstein PL; Bleisch TJ; Arnold MB; Kennedy JH; Wright RA; Johnson BG; Tizzano JP; Helton DR; Kallman MJ; Schoepp DD; Hérin M
    J Med Chem; 1998 Jan; 41(3):358-78. PubMed ID: 9464367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of aryl isoxazole derivatives as metabotropic glutamate receptor 1 antagonists: a potential treatment for neuropathic pain.
    Cho GH; Kim T; Son WS; Seo SH; Min SJ; Cho YS; Keum G; Jeong KS; Koh HY; Lee J; Pae AN
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1324-8. PubMed ID: 25677662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mGluR5, but not mGluR1, antagonist modifies MK-801-induced locomotor activity and deficit of prepulse inhibition.
    Pietraszek M; Gravius A; Schäfer D; Weil T; Trifanova D; Danysz W
    Neuropharmacology; 2005 Jul; 49(1):73-85. PubMed ID: 15992582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Methyl-3-(tetrahydro-2H-pyran-4-yl)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamides as a novel class of cannabinoid receptors agonists with low CNS penetration.
    Wei Z; Yang H; Liu Z; Tremblay M; Johnstone S; Béha S; Yue SY; Srivastava S; Tomaszewski MJ; Brown W; Walpole C; St-Onge S; Lessard E; Archambault AJ; Groblewski T; Pagé D
    Bioorg Med Chem Lett; 2012 Jun; 22(12):3884-9. PubMed ID: 22607668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC).
    Suzuki G; Kimura T; Satow A; Kaneko N; Fukuda J; Hikichi H; Sakai N; Maehara S; Kawagoe-Takaki H; Hata M; Azuma T; Ito S; Kawamoto H; Ohta H
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1144-53. PubMed ID: 17360958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-antipyrine-3, 4-dichloromaleimide, an effective cyclic imide for the treatment of chronic pain: the role of the glutamatergic system.
    Quintão NL; da Silva GF; Antonialli CS; de Campos-Buzzi F; Corrêa R; Filho VC
    Anesth Analg; 2010 Mar; 110(3):942-50. PubMed ID: 20185671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.